In the context of hypoxia, a key factor of tumor strength, G9a has been identified as a mediator of hypoxia-dependent gene repression either by catalyzing H3K9me2 or by modulating the expression or the activity of the master transcriptional regulator hypoxia-inducible factors (HIF)27–30. Here, EHMT2 is linked to neoplasm.